PlainRecalls
FDA Drug Moderate Class II Terminated

Gabapentin Capsules, USP 100mg 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-198-99

Reported: April 22, 2020 Initiated: March 18, 2020 #D-1232-2020

Product Description

Gabapentin Capsules, USP 100mg 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-198-99

Reason for Recall

CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Details

Recalling Firm
Aurobindo Pharma USA Inc.
Units Affected
26625 units
Distribution
Nationwide within the United States
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Gabapentin Capsules, USP 100mg 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-198-99. Recalled by Aurobindo Pharma USA Inc.. Units affected: 26625 units.
Why was this product recalled?
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Which agency issued this recall?
This recall was issued by the FDA Drug on April 22, 2020. Severity: Moderate. Recall number: D-1232-2020.